건강예보(Health Forecast)

0
건강예보(Health Forecast) is an Android app from Solmitech Co., Ltd., currently rated — across few ratings. Initial signal reads as no scraped reviews yet: judgment based on metadata only.
Quality Score is 0: Niche (micro-niche or pre-traction stage). For an app like this, that means micro-niche or pre-traction stage. The full BU Investment Matrix below scores 8 dimensions including monetisation, growth, and operational risk.
Track changes month-over-month in the Performance section below: live snapshot history and revenue forecast included.
- Title & subtitle keyword fit
- Description hook & conversion structure
- Screenshots, ratings, reviews strategy
📊 Performance Tracking LIVE
Synthetic estimate. Inputs: category complexity, file size, screen count, monetization layer, platform reach, age × team-size proxy. Calibrated against 2024-2026 indie-agency rate surveys. Full math + source list on /methodology.
| 🧱 MVP baseline (design + 1-store ship) | +$28K |
| 📱 5 unique screens × $4.5K | +$22K |
| 🌐 Cross-platform reach (iOS + Android) | +$27K |
| ⚙ 11.8y maintenance × ~1-person team | +$71K |
Synthetic estimate. Multiple band derived from ad-supported + age, rating quality, category demand, and user-base maturity. Calibrated against 2024-2026 indie-app-marketplace closed-deal medians. Full math + comparable deal list on /methodology.
| 📺 Ad-supported base | 15× MRR |
| 📅 11.8y proven track record | +20% |
Heuristic guess from app bundle size, category, store description signals, and release-date stack era. Bumetric does not disassemble binaries — for binary-level certainty you would need an SDK intelligence tool or the manifest itself. Reasoning chain on the right. Full ruleset on /methodology.
| 🏷 Category context | category |
| 📦 Compact Android bundle | → Native Kotlin |
How we forecast this revenue
LOW CONFIDENCEBU Investment Matrix
Pre-traction · 38/100INDIE TIERlimited signal- 💰 Revenue: Marginal — $200 - $1250/mo · INDIE tier · medium confidence, trajectory unclear.
- ⭐ Quality: None★ across 0 reviews — weak — significant quality concerns.
- 📍 Market: Not yet charting in any of the 9 monitored markets.
- 📈 Growth: Insufficient signal to assess trajectory.
- ⚠️ Risk: Low — no material risk signals detected.
💰 Forecast Revenue / mo
MODEL📈 Reviews Growth
LIVE⭐ Rating Trend
LIVEProfile & Insights
Identification
- App name
- 건강예보(Health Forecast)
- Developer
- Solmitech Co., Ltd.
- Bundle ID
- com.solmi.health_forecast
- App Store URL
- Not found
- Category
- Not found
- Content rating
- Not found
- Languages
- Not found
Company
- Website
- www.solmitech.co.kr
- Tagline
- Not found
- Description
- Not found
- Founded
- Not found
- HQ / Address
- Not found
- Employees
- Not found
- Logo
- Not found
Revenue
- Reported revenue signal / mo
- Not found
- AI revenue estimate / mo
- Not found
- AI annual estimate
- Not found
- Model estimate / mo
- $500/mo
- Top-grossing rank
- Not found
- All-time revenue
- Not found
- Pricing
- Not found
Founder
Funding
Press & Links
Contacts & Socials
📝 About this app
Solmi tech mobile storytelling music content
If you can get my health forecast?
Lest my heart to hear some music?
Can any picture and my heart?
We will solve these questions.
Health Forecast is content to use so that you can have fun with your health care measure pulse and stress level.
If do not need to worry about the device.
While the content is implemented without a measuring instrument to be used, when used in conjunction with SHC-M1 machine for sale in ㈜ solmi Tech can be measured more accurate health condition.
[Features]… View full description on the official store →
Track this app’s revenue
FREE📝 Description
95
More by Solmitech Co., Ltd.
View all →Why low confidence: only 0 ratings · no founder-verified revenue (model estimate only) · revenue figure is directional only.
건강예보(Health Forecast) is a very early-stage Android app with weak public traction — only 0 ratings, no founder-verified MRR, and not ranked in any monitored grossing chart. The app appears to be monetised, but public signals are too sparse for a precise revenue estimate.
Bottom line: treat all revenue, audience and acquisition-value numbers on this page as directional only — not founder-verified facts.




